Clinical Trial Update: Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial is evaluating talazoparib in combination with radiation therapy for locally recurrent gynecologic cancers, including cervical, endom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Endometrial Cancer
• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer
• Vaginal Cancer

Drugs mentioned

• Talzenna (talazoparib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Malignant Female Reproductive System Neoplasm, Recurrent Cervical Carcinoma | Phase 1 | Status: RECRUITING